American Journal of Obstetrics & Gynecology
Volume 200, Issue 2 , Pages 140.e1-140.e9 , February 2009

Oophorectomy as a risk factor for coronary heart disease

Presented at the Women's Reproductive Health Research Symposium, Rochester, NY, June 1-3, 2008; and at the American Association of Gynecologic Laparoscopists Annual Meeting, Las Vegas, NV, Oct. 29-Nov. 1.

  • Vanessa L. Jacoby, MD, MAS

      Affiliations

    • Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA
    • Corresponding Author InformationReprints: Vanessa Jacoby, MD, MAS, University of California, San Francisco, Women's Health Clinical Research Center, 1635 Divisadero St, Suite 600, San Francisco, CA 94115
    • ,
  • Deborah Grady, MD, MPH

      Affiliations

    • Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA
    • ,
  • George F. Sawaya, MD

      Affiliations

    • Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA

Received 26 January 2008 ,Revised 27 May 2008 ,Accepted 20 August 2008.

References 

  1. Kesharvarz H, Kieke B, Marchbanks P. Hysterectomy surveillance—United States, 1994-99. MMWR CDC Surveill Summ. 2002;51:1–8
  2. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol. 2008;198:34.e1–34.e7
  3. Lepine LM, Hillis SP, Koonin LM, Morrow B, Kierke BM, Wilcox LM. Hysterectomy Surveillance—United States, 1980-1993. MMWR CDC Surveill Summ. 1997;46:1–15
  4. Pokras MA, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health. 1988;78:852–853
  5. Averette HE, Nguyen HN. The role of prophylactic oophorectomy in cancer prevention. Gynecol Oncol. 1994;55(3 Pt 2):S38–S41
  6. Beard RW, Kennedy RG, Gangar KF, et al. Bilateral oophorectomy and hysterectomy in the treatment of intractable pelvic pain associated with pelvic congestion. Br J Obstet Gynaecol. 1991;98:988–992
  7. Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004;19:2152–2155
  8. Namnoum AB, Hickman TN, Goodman SB, Gehlbach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64:898–902
  9. Piver MS. Prophylactic oophorectomy: reducing the US death rate from epithelial ovarian cancer (A continuing debate). Oncologist. 1996;1:326–330
  10. American College of Obstetricians and Gynecologists. ACOG practice bulletin 7 (Clinical management guidelines for obstetrician-gynecologists). American College of Obstetricians and Gynecologists; 1999;
  11. Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol. 2003;85:363–366
  12. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril. 2002;77(Suppl 4):S42–S48
  13. Nathorst-Boos J, von Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest. 1992;34:97–101
  14. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy—effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol. 1993;14:283–293
  15. Melton LJ, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res. 2003;18:900–905
  16. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–1110
  17. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease (The Framingham Study). Ann Intern Med. 1978;89:157–161
  18. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol. 2002;155:339–345
  19. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med. 1999;159:1061–1066
  20. Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease?. J Clin Epidemiol. 1997;50:475–479
  21. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714–718
  22. Luoto T, Kaprio J, Reunanen A, Rutanen EM. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 1995;85:515–522
  23. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992;136:408–416
  24. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–226
  25. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting (Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group). JAMA. 2000;283:2008–2012
  26. Ritterband AB, Jaffe IA, Densen PM, Magagna JF, Reed E. Gonadal function and the development of coronary heart disease. Circulation. 1963;27:237–251
  27. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol. 2000;53:832–837
  28. Beard CM, Crowson CS, Malkasian GD, O'Fallon WM, Melton LJ. Cardiovascular disease and cancer risk following bilateral oophorectomy: a population-based study in Rochester, Minnesota. J Womens Health. 1995;4:133–141
  29. Broeders G. [The significance of the endocrine function of the ovaries for the prevention of coronary sclerosis and the adverse effects of early castration]. Ned Tijdschr Geneeskd. 1969;113:13–16
  30. Lokkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas. 2006;53:226–233
  31. Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16:556–562
  32. Casiglia E, Ginocchio G, Tikhonoff V, et al. Blood pressure and metabolic profile after surgical menopause: comparison with fertile and naturally-menopausal women. J Hum Hypertens. 2000;14:799–805
  33. Dringoli R, Cavallini F, Piccolomini A. [Electrocardiographic and clinical study of ovariectomized women and natural menopause]. Riv Ostet Ginecol. 1967;22:249–254
  34. Novotny A, Dvorak V, Kamarytova K. [Late consequences of surgical castration in women (author's translation)]. Schweiz Rundsch Med Prax. 1979;68:332–336
  35. Robinson RW, Higano N, Cohen WD. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Intern Med. 1959;104:908–913
  36. Howard BV, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation. 2005;111:1462–1470
  37. Svanberg L. Effects of estrogen deficiency in women castrated when young. Acta Obstet Gynecol Scand Suppl. 1981;106:11–15
  38. Hsia J, Barad D, Margolis K, et al. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (the Women's Health Initiative). Am J Cardiol. 2003;92:264–269
  39. Shelton JD. Prostacyclin from the uterus and woman's cardiovascular advantage. Prostaglandins Leukot Med. 1982;8:459–466
  40. Kannel WB, Gordon T, Wolf PA, McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke. 1972;3:409–420
  41. Naimark BJ, Ready AE, Sawatzky JA, et al. Serum ferritin and heart disease: the effect of moderate exercise on stored iron levels in postmenopausal women. Can J Cardiol. 1996;12:1253–1257
  42. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293–1294
  43. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med. 1992;85:889–896
  44. Langenberg P, Kjerulff KH, Stolley PD. Hormone replacement and menopausal symptoms following hysterectomy. Am J Epidemiol. 1997;146:870–880
  45. Brett KM, Madans JH. Hysterectomy use: The correspondence between self-reports and hospital records. Am J Public Health. 1994;84:1653–1655
  46. Kritz-Silverstein D, Von Muhlen DG, Ganiats TG, Barrett-Connor E. Hysterectomy status, estrogen use and quality of life in older women: the Rancho Bernardo study. Qual Life Res. 2004;13:55–62
  47. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–279
  48. Witteman JC, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989;298:642–644
  49. Parrish HM, Carr CA, Hall DG, King TM. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol. 1967;99:155–162

 Cite this article as: Jacoby VL, Grady D, Sawaya GF, et al. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 2009;200:140.e1-140.e9.

 This study was supported in part by Grant K12 HD001262 from the Women's Reproductive Health Research Career Development Program (to V.L.J.).

PII: S0002-9378(08)00981-2

doi: 10.1016/j.ajog.2008.08.045

American Journal of Obstetrics & Gynecology
Volume 200, Issue 2 , Pages 140.e1-140.e9 , February 2009

Article Tools

* Image Usage & Resolution